Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Thrombosis of Portal Venous System.”

76 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 76 results

Not applicableLooking for participantsNCT06054451
What this trial is testing

Clinical Diagnosis and Pathological Spectrum of Porto-sinusoidal Vascular Disease in India

Who this might be right for
Portal HypertensionBudd-Chiari SyndromeNon-Cirrhotic Portal Hypertension+4 more
Post Graduate Institute of Medical Education and Research, Chandigarh 210
Large-scale testing (Phase 3)Looking for participantsNCT03368651
What this trial is testing

The Impact on Survival of Neo-adjuvant Transarterial Chemoinfusion (TAI) for Patients With Hepatocellular Carcinoma And Portal Vein Tumor Thrombosis (PVTT) Who Underwent Hepatectomy : A Random, Controlled, Stage III Clinical Trial.

Who this might be right for
Hepatocellular Carcinoma
Sun Yat-sen University 230
Not applicableStudy completedNCT05012501
What this trial is testing

Analysis of Neutrophil Extracellular Traps in Hypercoagulability and Portal Vein Thrombosis in Liver Cirrhosis Patients

Who this might be right for
Neutrophil Extracellular Trap FormationPortal Vein ThrombosisLiver Cirrhosis
The Affiliated Hospital of Qingdao University 79
Early research (Phase 1)UnknownNCT04104074
What this trial is testing

Safety and Efficacy of Radiotherapy Plus Sintilimab for HCC With Portal Vein Tumor Thrombosis

Who this might be right for
Hepatocellular CarcinomaPortal Vein Tumor Thrombosis
Beijing Tsinghua Chang Gung Hospital 20
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07363512
What this trial is testing

Efficacy and Safety of Radiotherapy Combined With Tislelizumab and Anlotinib in the Treatment of Hepatocellular Carcinoma Complicated With Portal Vein Tumor Thrombus

Who this might be right for
HCC - Hepatocellular Carcinoma
Henan Cancer Hospital 27
Large-scale testing (Phase 3)Looking for participantsNCT06492395
What this trial is testing

Lenvatinib Plus DEB-TACE and HAIC vs. Lenvatinib Plus DEB-TACE for Large HCC With PVTT

Who this might be right for
Hepatocellular Carcinoma Non-resectable
Second Affiliated Hospital of Guangzhou Medical University 178
Post-approval studies (Phase 4)Study completedNCT04173429
What this trial is testing

Efficacy and Safety of Anticoagulant Therapy in Portal Vein Thrombosis

Who this might be right for
Liver CirrhosisPortal Vein Thrombosis
Qilu Hospital of Shandong University 64
Post-approval studies (Phase 4)Study completedNCT01952353
What this trial is testing

Preoperative Transarterial Chemoembolization for Resectable HCC With Portal Venous Invasion

Who this might be right for
Resectable Hepatocellular Carcinoma With Portal Vein Tumor Thrombus
Sun Yat-sen University 330
Large-scale testing (Phase 3)UnknownNCT04319484
What this trial is testing

Lenvatinib Following Liver Transplantation in Patients of Hepatocellular Carcinoma With Portal Vein Tumor Thrombus

Who this might be right for
Hepatocellular CarcinomaPortal Vein Tumor ThrombusLiver Transplantation
RenJi Hospital 108
Post-approval studies (Phase 4)Study completedNCT04645550
What this trial is testing

Apixaban, Warfarin and Aspirin Prevents Portal Vein Thrombosis in Patients After Laparoscopic Splenectomy（ESAWAAPT）

Who this might be right for
CirrhosisSplenectomy; StatusVenous Thrombosis+1 more
Northern Jiangsu People's Hospital 120
Not applicableStudy completedNCT05304455
What this trial is testing

Apixaban Prevents Portal Vein Thrombosis After Laparoscopic Splenectomy and Azygoportal Disconnection

Who this might be right for
CirrhosisSplenectomyVenous Thrombosis+1 more
Northern Jiangsu People's Hospital 40
Testing effectiveness (Phase 2)UnknownNCT04069949
What this trial is testing

Sorafenib Plus Toripalimab for Unresectable HCC With Portal Vein Tumor Thrombus

Who this might be right for
Unresectable Hepatocellular CancerPortal Vein Tumor Thrombus
Sichuan University 39
Post-approval studies (Phase 4)Ended earlyNCT01600196
What this trial is testing

Resection vs. Best Supportive Care for Hepatocellular Carcinoma (HCC) With Portal Venous Thrombus

Who this might be right for
Hepatocellular Carcinoma With Portal Vein Tumor Thrombus
Sun Yat-sen University 126
Not applicableUnknownNCT02485184
What this trial is testing

TIPS vs Endoscopic Therapy for Variceal Rebleeding in Cirrhotic Patients With Portal Vein Thrombosis

Who this might be right for
Portal Vein ThrombosisLiver Cirrhosis
Air Force Military Medical University, China 120
Not applicableUnknownNCT03322696
What this trial is testing

ADAMTS-13 LEVEL AS PREDICTIVE BIOMARKER FOR DEVELOPMENT OF PORTAL VEIN THROMBOSIS IN LIVER CIRRHOSIS (ADAPTHRO)

Who this might be right for
Liver Cirrhosis
Raimondo De Cristofaro 118
Testing effectiveness (Phase 2)UnknownNCT05872841
What this trial is testing

H101 Combined With TACE for Primary Hepatocellular Carcinoma With Portal Vein Thrombosis

Who this might be right for
Primary Hepatocellular CarcinomaPortal Vein Thrombosis
Tianjin Medical University Cancer Institute and Hospital 38
Large-scale testing (Phase 3)UnknownNCT02627053
What this trial is testing

Treatment of Splanchnic Vein Thrombosis With Rivaroxaban. A Pilot, Prospective Cohort Study

Who this might be right for
Portal Vein ThrombosisMesenteric Vein ThrombosisSplenic Vein Thrombosis
Università degli Studi dell'Insubria 100
Testing effectiveness (Phase 2)Study completedNCT03009461
What this trial is testing

Sorafenib Plus Hepatic Arterial Infusion Versus Sorafenib for HCC with Major Portal Vein Tumor Thrombosis

Who this might be right for
HepatoCellular CarcinomaPortal Vein Thrombosis
Peking University 64
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07122089
What this trial is testing

Evaluation of SIRT Followed by Immunotherapy for Treatment of Hepatocellular Carcinoma With Portal Vein Thrombosis

Who this might be right for
Hepatocellular Carcinoma Non-resectable
Center Eugene Marquis 80
Not applicableUnknownNCT05491889
What this trial is testing

Outcome of Hepatocellular Carcinoma Patients With Portal Vein Thrombosis After Trans-Arterial Chemo Embolization

Who this might be right for
Hepatocellular Carcinoma
Assiut University 30
Load More Results